Search Results

LY2811376 100mg 100mg  | Purity Not Available

Adooq Bioscience

LY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.

More Information Supplier Page

LY2811376 10mg 10mg  | Purity Not Available

Adooq Bioscience

LY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.

More Information Supplier Page

SL251188 25mg 25mg  | Purity Not Available

Adooq Bioscience

SL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).

More Information Supplier Page

SL251188 5mg 5mg  | Purity Not Available

Adooq Bioscience

SL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).

More Information Supplier Page

PF 670462 100mg 100mg  | Purity Not Available

Adooq Bioscience

PF 670462 inhibits PER protein nuclear translocation (EC50 = 290 nM) causing phase shifts in circadian rhythms and attenuates methamphetamine-stimulated locomotion in vivo.

More Information Supplier Page

PF 670462 10mg 10mg  | Purity Not Available

Adooq Bioscience

PF 670462 inhibits PER protein nuclear translocation (EC50 = 290 nM) causing phase shifts in circadian rhythms and attenuates methamphetamine-stimulated locomotion in vivo.

More Information Supplier Page